Institute for Quality and Efficiency in Health Care, Cologne, Germany.
PLoS One. 2013;8(3):e59213. doi: 10.1371/journal.pone.0059213. Epub 2013 Mar 14.
Health Technology Assessments (HTAs) are used to inform decision-making and their usefulness depends on the quality and relevance of research and specific studies for health-policy decisions. Little is known about the country of origin of studies used for HTAs.
To investigate which countries have made the largest contributions to inform health policy decisions through studies included in HTAs in Germany.
The country of origin was extracted from all studies included in HTAs of the German Institute for Quality and Efficiency in Health Care, (IQWiG), published from 2/2006 to 9/2010. Studies were ranked according to the total number of studies per country, adjusted for population size, gross domestic product (GDP), and total health expenditure.
1087 studies were included in 54 HTA reports. Studies were assigned to 45 countries. Most of the studies (27%) originated from the United States (USA), 18% were multinational, followed by 7% from the United Kingdom (UK) and 5% from Germany. Nordic countries led the ranking when adjusting for population size/million (ranks 1-3,6,9/45 countries), GDP/billion US$ (1,2,5,9,14/45), or health expenditure/billion US$ (1,3,5,12,13/45). The relative contribution of the UK was stable in the analyses when adjusted for population size (7/45), GDP (7/45), and health expenditure (9/45), whereas the USA (13, 18, and 30/45) and Germany (17, 19, and 21/45) dropped in the ranking.
More than half of the studies relevant for evidence-informed decision-making in Germany originated from the USA, followed by multinational research and the UK. Only 5% of the studies originated from Germany. According to our findings, there appears to be some discrepancy between the use of globally generated evidence and the contribution to the knowledge pool by individual countries.
卫生技术评估(HTA)用于为决策提供信息,其有用性取决于针对卫生政策决策的研究和具体研究的质量和相关性。对于 HTA 中使用的研究的来源国知之甚少。
调查通过德国卫生保健质量和效率研究所(IQWiG)的 HTA 中包含的研究,哪些国家对告知卫生政策决策做出了最大贡献。
从 2006 年 2 月至 2010 年 9 月发表的德国卫生保健质量和效率研究所(IQWiG)的所有 HTA 中提取研究的来源国。根据每个国家的研究总数对研究进行排名,根据人口规模、国内生产总值(GDP)和总卫生支出进行调整。
54 份 HTA 报告共纳入 1087 项研究。研究分配给 45 个国家。大多数研究(27%)来自美国(USA),18%为跨国研究,其次是英国(UK)占 7%,德国占 5%。当按人口规模/百万(排名 1-3、6、9/45 个国家)、GDP/十亿美元(1、2、5、9、14/45)或卫生支出/十亿美元(1、3、5、12、13/45)进行调整时,北欧国家在排名中名列前茅。当按人口规模(7/45)、GDP(7/45)和卫生支出(9/45)进行调整时,英国的相对贡献保持稳定,而美国(13、18 和 30/45)和德国(17、19 和 21/45)的排名则有所下降。
德国用于循证决策的相关研究中,有一半以上来自美国,其次是跨国研究和英国。只有 5%的研究来自德国。根据我们的发现,在使用全球产生的证据和个别国家对知识体系的贡献之间似乎存在一些差异。